Turn Biotechnologies is a biotechnology company focused on epigenetic reprogramming to fight age-related diseases and repair damaged tissue. The company develops mRNA-based therapies aimed at restoring youthful cell function at the genome level and uses proprietary delivery technologies to target specific tissues or organs. Their ERA (Epigenetic Reprogramming of Age) platform represents a novel approach in cellular programming to rejuvenate cells while preserving identity. The organization is based in the San Francisco Bay Area with research and development activities in Mountain View, CA.
No recent news for this company.
No recent deals for this company.